Search Results - "Marshall, Richard P"
-
1
Dissecting fibrosis: therapeutic insights from the small-molecule toolbox
Published in Nature reviews. Drug discovery (01-10-2015)“…Key Points The search for new therapeutics for fibrosis has recently increased owing to recent drug approvals coupled with advances in mechanistic insight and…”
Get full text
Journal Article -
2
Mepolizumab, a humanized anti–IL-5 mAb, as a treatment option for severe nasal polyposis
Published in Journal of allergy and clinical immunology (01-11-2011)“…Background Approximately 85% of nasal polyps (NPs) in white subjects are characterized by prominent eosinophilia. IL-5 is the key driver of eosinophilic…”
Get full text
Journal Article Web Resource -
3
Daily Home Spirometry: An Effective Tool for Detecting Progression in Idiopathic Pulmonary Fibrosis
Published in American journal of respiratory and critical care medicine (15-10-2016)“…Recent clinical trial successes have created an urgent need for earlier and more sensitive endpoints of disease progression in idiopathic pulmonary fibrosis…”
Get full text
Journal Article -
4
The mTORC1/4E-BP1 axis represents a critical signaling node during fibrogenesis
Published in Nature communications (02-01-2019)“…Myofibroblasts are the key effector cells responsible for excessive extracellular matrix deposition in multiple fibrotic conditions, including idiopathic…”
Get full text
Journal Article -
5
Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma
Published in The New England journal of medicine (05-03-2009)“…Asthma exacerbations are characterized by increased symptoms of cough and chest tightness, diminished expiratory airflow, and increased numbers of inflammatory…”
Get full text
Journal Article -
6
Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre PROFILE study
Published in The lancet respiratory medicine (01-06-2015)“…Summary Background Idiopathic pulmonary fibrosis, a progressive and inevitably fatal disorder, has a highly variable clinical course. Biomarkers that reflect…”
Get full text
Journal Article -
7
Exploration of a potent PI3 kinase/mTOR inhibitor as a novel anti-fibrotic agent in IPF
Published in Thorax (01-08-2016)“…Idiopathic pulmonary fibrosis (IPF) is the most rapidly progressive and fatal of all fibrotic conditions with no curative therapies. Common pathomechanisms…”
Get more information
Journal Article -
8
An epithelial biomarker signature for idiopathic pulmonary fibrosis: an analysis from the multicentre PROFILE cohort study
Published in The lancet respiratory medicine (01-12-2017)“…Idiopathic pulmonary fibrosis (IPF) is a progressive, fatal disorder with a variable disease trajectory. The aim of this study was to assess potential…”
Get full text
Journal Article -
9
Quantitative computed tomography–derived clusters: Redefining airway remodeling in asthmatic patients
Published in Journal of allergy and clinical immunology (01-03-2014)“…Background Asthma heterogeneity is multidimensional and requires additional tools to unravel its complexity. Computed tomography (CT)–assessed proximal airway…”
Get full text
Journal Article -
10
Biomarkers of collagen synthesis predict progression in the PROFILE idiopathic pulmonary fibrosis cohort
Published in Respiratory research (12-07-2019)“…Idiopathic pulmonary fibrosis (IPF) is characterised by excessive extracellular matrix (ECM) deposition and remodelling. Measuring this activity provides an…”
Get full text
Journal Article -
11
Relationship between lung function and quantitative computed tomographic parameters of airway remodeling, air trapping, and emphysema in patients with asthma and chronic obstructive pulmonary disease: A single-center study
Published in Journal of allergy and clinical immunology (01-05-2016)“…Background There is a paucity of studies comparing asthma and chronic obstructive pulmonary disease (COPD) based on thoracic quantitative computed tomographic…”
Get full text
Journal Article -
12
A positron emission tomography imaging study to confirm target engagement in the lungs of patients with idiopathic pulmonary fibrosis following a single dose of a novel inhaled αvβ6 integrin inhibitor
Published in Respiratory research (26-03-2020)“…Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive lung disease with poor prognosis and a significant unmet medical need. This study evaluated the…”
Get full text
Journal Article -
13
The topical study of inhaled drug (salbutamol) delivery in idiopathic pulmonary fibrosis
Published in Respiratory research (06-02-2018)“…Our aim was to investigate total and regional lung delivery of salbutamol in subjects with idiopathic pulmonary fibrosis (IPF). The TOPICAL study was a…”
Get full text
Journal Article -
14
Author Correction: The mTORC1/4E-BP1 axis represents a critical signaling node during fibrogenesis
Published in Nature communications (11-09-2020)“…An amendment to this paper has been published and can be accessed via a link at the top of the paper…”
Get full text
Journal Article -
15
Severe Asthma: differential chemokine response of airway epithelial cells
Published in Journal of allergy and clinical immunology (01-10-2017)“…The differential chemokine response of airway basal cells of severe asthma patients to Streptococcus pneumoniae and Dermatophagoides pteronyssinus allergen may…”
Get full text
Journal Article -
16
Angiotensin II and the fibroproliferative response to acute lung injury
Published in American journal of physiology. Lung cellular and molecular physiology (01-01-2004)“…Angiotensin II (ANG II), generated by activation of local renin-angiotensin systems, is believed to play an important role in tissue repair and remodeling, in…”
Get more information
Journal Article -
17
Fibroproliferation occurs early in the acute respiratory distress syndrome and impacts on outcome
Published in American journal of respiratory and critical care medicine (01-11-2000)“…The fibroproliferative phase of acute respiratory distress syndrome (ARDS) has traditionally been regarded as a late event but recent studies that suggest…”
Get full text
Journal Article -
18
Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine
Published in The New England journal of medicine (16-12-2021)“…In a randomized, double-blind, placebo-controlled phase 3 trial of the ChAdOx1 nCoV-19 vaccine in over 32,000 participants from the United States, Chile, and…”
Get full text
Journal Article -
19
Reduced need for surgery in severe nasal polyposis with mepolizumab: Randomized trial
Published in Journal of allergy and clinical immunology (01-10-2017)“…Patients with eosinophilic nasal polyposis frequently require surgery, and recurrence rates are high. We sought to assess the efficacy and safety of…”
Get full text
Journal Article -
20
Angiotensin II is mitogenic for human lung fibroblasts via activation of the type 1 receptor
Published in American journal of respiratory and critical care medicine (01-06-2000)“…The expression of renin-angiotensin system components and the elevation of angiotensin-converting enzyme (ACE) in a number of fibrotic lung diseases suggests…”
Get full text
Journal Article